Last reviewed · How we verify
NCT02910661: TAKE-IT TOO
Teen Adherence in KidnEy Transplant, Improving Tracking To Optimize Outcomes (Stage 1)
trial testing Focus Group in Medication Adherence in 95 participants. Completed in 6 August 2017.
6 August 2017
Quick facts
| Lead sponsor | Beth Foster |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 95 |
| Start date | 28 March 2017 |
| Primary completion | 6 August 2017 |
| Estimated completion | 6 August 2017 |
| Sites | 9 locations across Canada, United States |
Drugs / interventions tested
- Focus Group
Conditions studied
- Medication Adherence — all drugs for Medication Adherence →
Sponsor
Beth Foster
Who can join
Adults 12 to 70, any sex, with Medication Adherence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall goal of the Teen Adherence in KidnEy transplant Improving Tracking TO Optimize Outcomes (TAKE-IT TOO) study is to adapt the successful TAKE-IT intervention, aimed at improving medication adherence in adolescent kidney transplant, for use in 'real world' clinical care. The specific aims of Stage 1 of this study are: (1) To understand the needs and preferences of stakeholders (kidney transplant recipients, parents, and healthcare professionals (HCP)) in order to optimize the TAKE-IT intervention for 'real world' use.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02910661
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Focus Group
Trials testing the same drug.
- NCT06786104 — Video Inspired Discussions About Ethical Outcomes in Pediatrics · NA · not yet recruiting
- NCT07049757 — Healthy Family Project: Tobacco Use and Smoke Exposure in Asian American Communities · NA · recruiting
- NCT06432985 — Smoking Cessation CM for Veterans With or at Risk for Cancer · NA · recruiting
- NCT06549153 — ACT-Together (Acting on Cancer Testing-Together) · NA · active not recruiting
- NCT06559462 — Nudge Strategies for DPYD Testing in Patients With Gastrointestinal Cancers Treated With Fluoropyrimidines · NA · completed
Other recruiting trials for Medication Adherence
Currently open trials in the same condition.
- NCT07420634 — Multilevel Ecological and COM-B Determinants of Medication Adherence in Adults With Diabetes · recruiting
- NCT06876233 — Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication · NA · recruiting
- NCT05624931 — Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa · NA · recruiting
- NCT06949774 — INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND) · NA · recruiting
- NCT06569290 — Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Sci · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02910661 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beth Foster
- Last refreshed: 28 September 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02910661.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing